Press Releases Biocure Technology Inc.

Equities

CURE

CA09075T1075

Market Closed - Canadian Securities Exchange Other stock markets 09:30:00 2023-09-11 am EDT			5-day change	1st Jan Change
0.015 ^CAD	-25.00%		-.--%	-.--%

2023	Biocure Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Atriva Therapeutics GmbH announced that it expects to receive $15 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology	23-09-18	AQ
Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction	23-09-18	NE
Canadian Investment Regulatory Organization Trading Halt - CURE	23-09-14	AQ
Biocure Technology : “CURE”) Announces Resignation of a Director, Appointment of New CEO	23-09-07	PU
Biocure Technology : Clarification News Release	23-02-02	PU
BiocurePharm, Korea Announces Private Placement	22-12-29	AQ
Biocure Technology : BiocurePharm, Korea (“BPK”) Announces Private Placement	22-12-28	PU
Biocure Technology : “CURE”) Announces Resignation of a Director	22-12-22	PU
Biocure Technology : Enters into Agreement on Pharm Corporation	22-12-19	PU
Biocure Technology : “CURE”) Announces Shares for Debt Transaction	22-12-13	PU
Biocure Technology : Corporate Update	22-09-07	PU
Biocure Technology : Interim Financial Report	21-12-07	PU
Biocure Technology : Management Discussion and Analysis	21-12-07	PU
Biocure Technology Inc :. Announces Focus on its own CAR T-cell Therapy Targeting Chronic Lymphocytic Leukemia ('CLL') and Solid Tumor Cancers and Intent to Apply for Patents	21-08-31	AQ
BioCure Technology Inc. Announces Closing of Financing	21-07-14	NE
BioCure Technology Inc. Commences Dual Listing in Germany and Announces New Contracts	21-06-28	NE
BiocurePharm, Korea (BPK) Signs MOU With Symbasis GmbH to Develop CAR-T Therapy for Chronic Lymphocyte Leukemia (CLL)	21-01-04	NE
Biocure Technology : BiocurePharm Korea Announces the Submission of IND Application for Phase 1 Trial of CD19 CAR-T Therapy	20-12-31	AQ
BiocurePharm, Korea ("BPK") Announces the Submission of IND Application for Phase 1 Trial of CD19 CAR-T Therapy	20-12-30	NE
BioCure Technology : Announces Closing of Financing	20-10-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biocure Technology Inc.

Equities

CURE

CA09075T1075

Press Releases

Filters